Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

PFE – Pfizer Inc.

Pfizer, Inc.
PFE
$24.19
Name : Pfizer, Inc.
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $137,529,098,240.00
EPSttm : 1.38
finviz dynamic chart for PFE
Pfizer, Inc.
$24.19
0.21%
$0.05

Float Short %

1.88

Margin Of Safety %

27

Put/Call OI Ratio

0.92

EPS Next Q Diff

-0.06

EPS Last/This Y

-0.11

EPS This/Next Y

0.09

Price

24.19

Target Price

28.11

Analyst Recom

2.44

Performance Q

-3.28

Relative Volume

0.83

Beta

0.54

Ticker: PFE




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02PFE23.460.840.483152160
2025-06-03PFE23.360.840.383172589
2025-06-04PFE23.410.840.673186461
2025-06-05PFE23.110.851.193205758
2025-06-06PFE23.330.840.393217289
2025-06-09PFE23.960.850.443140861
2025-06-10PFE24.310.830.703203273
2025-06-11PFE24.480.840.693264548
2025-06-12PFE24.850.840.543304094
2025-06-13PFE24.550.850.553324216
2025-06-16PFE24.410.860.783267297
2025-06-17PFE240.870.803299575
2025-06-18PFE23.890.870.523301088
2025-06-20PFE23.960.860.673314320
2025-06-23PFE24.040.960.542617860
2025-06-24PFE24.30.950.452665379
2025-06-25PFE24.280.940.282705844
2025-06-26PFE24.250.930.372726595
2025-06-27PFE24.230.920.122751298
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02PFE23.46-6.311133.33.00
2025-06-03PFE23.35-6.311078.03.00
2025-06-04PFE23.40-6.311188.43.00
2025-06-05PFE23.12-6.310967.33.00
2025-06-06PFE23.33-6.311300.03.00
2025-06-09PFE23.97-6.311582.63.00
2025-06-10PFE24.30-6.311377.53.00
2025-06-11PFE24.49-6.311281.23.00
2025-06-12PFE24.84-6.311393.93.00
2025-06-13PFE24.53-6.310949.23.00
2025-06-16PFE24.41-6.311067.03.00
2025-06-17PFE23.99-6.310879.53.00
2025-06-18PFE23.88-6.311072.53.00
2025-06-20PFE23.97-6.311214.93.00
2025-06-23PFE24.02-6.311191.13.00
2025-06-24PFE24.31-6.311343.23.00
2025-06-25PFE24.29-6.311140.43.00
2025-06-26PFE24.25-6.311126.93.00
2025-06-27PFE24.19-6.311120.23.00
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02PFE0.170.221.89
2025-06-03PFE0.170.221.89
2025-06-04PFE0.170.221.89
2025-06-05PFE0.170.221.89
2025-06-06PFE0.170.221.89
2025-06-09PFE0.170.241.89
2025-06-10PFE0.170.241.89
2025-06-11PFE0.170.241.85
2025-06-12PFE0.170.241.85
2025-06-13PFE0.170.241.85
2025-06-16PFE0.170.761.85
2025-06-17PFE0.170.761.85
2025-06-18PFE0.170.761.85
2025-06-20PFE0.170.761.85
2025-06-23PFE0.170.541.85
2025-06-24PFE0.170.541.85
2025-06-25PFE0.170.541.85
2025-06-26PFE0.170.541.88
2025-06-27PFE0.170.541.88
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

0.92

Avg. EPS Est. Current Quarter

0.56

Avg. EPS Est. Next Quarter

0.86

Insider Transactions

0.17

Institutional Transactions

0.54

Beta

0.54

Average Sales Estimate Current Quarter

13426

Average Sales Estimate Next Quarter

17112

Fair Value

30.82

Quality Score

83

Growth Score

59

Sentiment Score

62

Actual DrawDown %

60.8

Max Drawdown 5-Year %

-59

Target Price

28.11

P/E

17.53

Forward P/E

7.84

PEG

P/S

2.2

P/B

1.52

P/Free Cash Flow

12.26

EPS

1.38

Average EPS Est. Cur. Y​

3

EPS Next Y. (Est.)

3.09

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

12.59

Relative Volume

0.83

Return on Equity vs Sector %

-15.2

Return on Equity vs Industry %

-23.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

11120.2
Pfizer, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 81000
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
stock quote shares PFE – Pfizer Inc. Stock Price stock today
news today PFE – Pfizer Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PFE – Pfizer Inc. yahoo finance google finance
stock history PFE – Pfizer Inc. invest stock market
stock prices PFE premarket after hours
ticker PFE fair value insiders trading